Slingshot members are tracking this event:

Phase 3 IMpassion 130 data of AstraZeneca's (AZN) Tecentriq (atezolizumab) In breast cancer expected Q2 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AZN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 02, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Tecentriq, Atezolizumab, Breast Cancer